Indian Markets Flatline; Midcaps Shine as Nifty Holds 26,100

ECONOMY
Whalesbook Logo
AuthorVihaan Mehta|Published at:
Indian Markets Flatline; Midcaps Shine as Nifty Holds 26,100
Overview

Indian equity benchmarks, Sensex and Nifty, recovered from intraday lows to finish near flat on Wednesday. Midcap stocks significantly outperformed, with the Nifty Midcap index gaining 276 points, while the Nifty 50 held above 26,100. Select banking stocks and Maruti Suzuki weighed on benchmarks, limiting gains.

Markets Close Near Flatline

Indian equity benchmarks staged a late recovery on Wednesday, January 7, 2026, to close just shy of breakeven. The benchmark BSE Sensex shed 102 points, settling at 84,961, while the NSE Nifty 50 dipped 38 points to 26,141. Broader market indices, however, significantly outperformed the headline gauges, signalling investor preference for smaller cap stocks.

Midcaps Lead the Charge

The Nifty Midcap index posted a strong gain of 276 points, closing at 61,425. This surge in midcap shares helped maintain positive market breadth, with advances marginally outnumbering declines. The Nifty Bank index, conversely, bucked the trend, falling 128 points to 59,991, pressured by weakness in prominent banking counters.

Sectoral Movers and Shakers

Information technology stocks provided crucial support to the benchmarks, absorbing some of the selling pressure. However, heavyweights like HDFC Bank and major auto manufacturers acted as a drag on the Nifty. Maruti Suzuki India Ltd saw profit booking after reaching record highs, declining up to 5% intraday. Tata Motors' passenger vehicle business also faced headwinds following its quarterly update, with its stock slipping nearly 2%.

Stock Specific Action

Auto engineering and R&D firms like Tata Elxsi and KPIT Technologies surged between 6% and 10% on positive brokerage sentiment. Jewellery stocks, including Titan, Senco Gold, and Kalyan Jewellers, witnessed robust buying, climbing 4% to 11% on the back of strong third-quarter results. Midcap pharmaceutical companies like Lupin and Torrent Pharmaceuticals attracted investment ahead of their results. Cipla was the day's top loser among Nifty constituents after its drug partner received US FDA observations. Hindustan Zinc closed over 2% lower on declining silver prices. Lemon Tree Hotels jumped over 4% on potential stake acquisition news by Warburg Pincus.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.